Mid-Atlantic BioTherapeutics (MABT) Funding & Investors

Doylestown, PA

Mid-Atlantic BioTherapeutics they are focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases. They are actively addressing the growing antibiotic resistance problems and creating a revolutionary treatment paradigm for viral diseases (e.g., the Tamiflu alternative for influenza), emerging infectious diseases, and biodefense.